Multi-drug Resistance in Emerging and Re-emerging DiseasesThis volume highlights the state-of-the-art in microbial / parasite control and containment and discusses ways and means of avoiding development of drug resistance. Topics discussed include Malaria, Tuberculosis, Cholera, Leprosy, Diarrhoeal Diseases, Nosocomial Diseases, Plague, Drug Resistance and Cancer |
Contents
Drug Resistance in Cancer | 1 |
Its Impact on Treatment of Aids and TB | 15 |
Current Pandemics of Cholera and Strategy | 23 |
Copyright | |
22 other sections not shown
Other editions - View all
Multi-Drug Resistance in Emerging and Re-Emerging Diseases R. C. Mahajan,Amu Therwath Limited preview - 2001 |
Common terms and phrases
Agents Chemother ahpC ALAD analysis antibiotics antibodies antigens antimalarial Antimicrob artemisinin assay bacterial bactericidal activity bovis cancer catalase-peroxidase cell chemotherapy chloroquine chloroquine resistance cholerae 01 choline Clin clinical clone coli detection disease drug resistance El Tor encoding enzyme epidemic epidemiology erythrocytes expression genetic genome heme HIV infection host identified India inhA inhibition isolates isoniazid isoniazid resistance katG gene Katoch Lepr lepromatous leprosy leukaemia levels malaria malaria parasite MB leprosy mechanisms mefloquine membrane methods mice Microbiol molecular multidrug resistance mycobacterial promoters Mycobacterium leprae Mycobacterium tuberculosis mycolic acid OFLO pathogenic pathway patients plague plasmid Plasmodium falciparum point mutations polymerase polymorphism probes proportion of viable protein pyrimethamine reductase regimens resistant strains ribotyping rifampicin rifampin sequence serogroup Sharma smegmatis specific studies susceptibility synthesis target therapy transmission treatment tuberculosis complex vector Vibrio cholerae virulence vitro vivax vivo